Drug-drug interactions with tyrosine kinase inhibitors

被引：0
|
作者：
Janus, N. [1 ]
机构：
[1] LEO Pharma, Global Med Affairs, Voisins Le Bretonneaux, France
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.1926
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1623P
引用
收藏
页码：S1283 / S1283
页数：1
相关论文
共 50 条
  • [1] Drug-drug interactions with tyrosine-kinase inhibitors
    Croes, Sander
    de Vries, Frank
    LANCET ONCOLOGY, 2014, 15 (10): : E416 - E416
  • [2] Drug-drug interactions in patients receiving tyrosine kinase inhibitors
    Keller, Kristine L.
    Franquiz, Miguel J.
    Duffy, Alison P.
    Trovato, James A.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (02) : 110 - 115
  • [3] Drug-drug interactions with tyrosine-kinase inhibitors: a clinical perspective
    van Leeuwen, Roelof W. F.
    van Gelder, Teun
    Mathijssen, Ron H. J.
    Jansman, Frank G. A.
    LANCET ONCOLOGY, 2014, 15 (08): : E315 - E326
  • [4] Drug-drug interactions in patients using tyrosine kinase inhibitors: A multicenter retrospective study
    Ergun, Yakup
    Ozdemir, Nuriye Yildirim
    Toptas, Serife
    Kurtipek, Alican
    Eren, Tulay
    Yazic, Ozan
    Sendur, Mehmet Ali Nahit
    Akinci, Bulent
    Ucar, Gokhan
    Oksuzoglu, Berna
    Uncu, Dogan
    JOURNAL OF BUON, 2019, 24 (04): : 1719 - 1726
  • [5] Tyrosine kinase inhibitors (TKI): Awareness of drug-drug interaction
    Ozdemir, N.
    Toptas, S.
    Sendur, M. A. N.
    Yazici, O.
    Oksuzoglu, B.
    Silay, K.
    Zengin, N.
    ANNALS OF ONCOLOGY, 2017, 28
  • [6] The Role of Organic Cation Transporters in the Pharmacokinetics, Pharmacodynamics and Drug-Drug Interactions of Tyrosine Kinase Inhibitors
    Xiu, Fangrui
    Rausch, Magdalena
    Gai, Zhibo
    Su, Shanshan
    Wang, Shijun
    Visentin, Michele
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [7] Drug-drug interactions of tyrosine kinase inhibitors in treatment of non-small-cell lung carcinoma
    Libiad, Youssef
    Boutayeb, Saber
    Chaibi, Aicha
    BULLETIN DU CANCER, 2022, 109 (03) : 358 - 381
  • [8] Identifying the reactive metabolites of tyrosine kinase inhibitors in a comprehensive approach: Implications for drug-drug interactions and hepatotoxicity
    Paludetto, Marie-Noelle
    Puisset, Florent
    Chatelut, Etienne
    Arellano, Cecile
    MEDICINAL RESEARCH REVIEWS, 2019, 39 (06) : 2105 - 2152
  • [9] Clinical pharmacokinetics and drug-drug interactions of tyrosine-kinase inhibitors in chronic myeloid leukemia: A clinical perspective
    Cheng, Fang
    Wang, Hongxiang
    Li, Weiming
    Zhang, Yu
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 195
  • [10] Comparison of drug-drug interaction checking databases for interactions involving BCR-ABL tyrosine kinase inhibitors
    Gunay, Ayse
    Demirpolat, Eren
    Yerer, Muekerrem Betul
    Unal, Ali
    ISTANBUL JOURNAL OF PHARMACY, 2024, 54 (01): : 32 - 39
12345